Oncology Impact Fund (Cayman) Management L.P., 10% Owner at iTeos Therapeutics, Inc. (ITOS), sold 168,690 shares at $27.01 ($4.6M) on 2021-10-08, disclosed to the SEC on 2021-10-12.
Open-market sale of $4.6M ITOS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.00 | 1,922 | $52K | 1.1% |
| 2 | $27.01 | 3,400 | $92K | 2.0% |
| 3 | $27.24 | 81,684 | $2.2M | 48.4% |
| 4 | $27.24 | 81,684 | $2.2M | 48.4% |
| Total | $27.23 avg | 168,690 | $4.6M | 100% |
| Filing → |
| ITOS | SELL | 2021-11-24 | $8.9M | — | Filing → |
| ITOS | SELL | 2021-10-18 | $1.6M | — | Filing → |
| ITOS | SELL | 2021-09-20 | $8.7M | — | Filing → |